DOD Biotech Public Company Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €16.97M -4.8% -€4.19M -2,317.0% -24.7% -0.26 pp €1.51M +40.2% 8.9% +0.029 pp
    €17.83M +26.2% €188.98K -102.1% 1.1% +0.65 pp €1.07M -160.6% 6.0% +0.19 pp
    €14.12M -47.1% -€9.08M -248.1% -64.2% -0.87 pp -€1.77M -120.6% -12.6% -0.45 pp
    €26.70M -37.0% €6.13M +65.0% 23.0% +0.14 pp €8.62M -26.9% 32.3% +0.044 pp
    €42.37M +104.0% €3.71M +62.9% 8.8% -0.022 pp €11.80M +82.0% 27.9% -0.034 pp
    €20.77M +18.5% €2.28M -71.6% 11.0% -0.35 pp €6.49M +139.4% 31.2% +0.16 pp
    €17.52M +81.3% €8.03M +120.0% 45.8% +0.081 pp €2.71M -62.4% 15.5% -0.59 pp
    €9.67M -4.5% €3.65M +7.7% 37.8% +0.043 pp €7.20M +17.2% 74.4% +0.14 pp
    €10.12M +126.8% €3.39M +172.7% 33.5% +0.056 pp €6.14M -1,594.0% 60.7% +0.70 pp
    €4.46M +8,089.8% €1.24M -9,616.5% 27.9% +0.52 pp -€411.11K -∞% -9.2% -0.092 pp
    €54.49K -0.1% -€13.06K +0.0% -24.0% -0.00013 pp €0.00 +NaN% 0.0% +0.0 pp
    €54.52K -€13.06K -24.0% €0.00 0.0%

    Notifications